Sollzo, 3 More London Riverside, London (2026)

12/08/2021

📌SOLLZO's profit on assets in the biotech sector rose 35%!

Dear Investors!

📈Investments in shares of large pharmaceutical companies account for more than 13% of SOLLZO's total investment portfolio, and the company's return on these assets often exceeds 40%.

⬆️Since the beginning of August 2021, SOLLZO's profit on assets in the biotechnology sector has grown by 35%.

Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) MRNA have raised the COVID-19 vaccine prices in their latest contract negotiations with the European Union. Pfizer will now charge 19.50 euros ($23) a shot, in comparison to the 15.50 euros ($18.40) charged previously. Moderna will now charge 25.50 euros ($30.30) per shot against the prior price of 19 euros ($22.60).

In the United States, as in other countries, new cases of the delta variant are on the rise. According to the Centers for Disease Control and Prevention (CDC), the number of cases has increased by at least 50% in the past seven days in 36 states (as of July 29).

The delta variant is a serious concern as the number of new cases arising from the variant is being mostly observed among the unvaccinated population. In order to combat the situation, President Joe Biden has informed about some new initiatives to improve the vaccination rate. One of the measures include making it mandatory for all federal employees to attest to being vaccinated or deal with strict protocols, according to a CNN report.

💉Major companies are also making it mandatory for their employees to get vaccinated before returning to company campuses. Important names like Google GOOGL, Facebook (NASDAQ:FB) FB, Netflix (NASDAQ:NFLX) and BlackRock (NYSE:BLK) can be safely added to the list of companies with a vaccine mandate.

Thus, the demand for vaccines will be high, and the biotechnology sector for our company will remain profitable in the long term.

Get consistent, high returns on high-value assets at the intersection of two powerful and dynamic industries - healthcare and real estate.

💰By investing with SOLLZO, you are investing in your well-being!

,

09/08/2021

📌SOLLZO has issued an insurance policy for investor deposits in the amount of $ 150 million.

Dear Investors!

💎SOLLZO is a strong company with many years of experience in successful asset management. Our investment project provides consistently high returns for investors and capital partners.

In addition to high profitability, the key point when making an investment decision is the level of risks and the degree of protection of the invested funds.

While developing a comprehensive strategy to minimize risks, we paid special attention to the safety of our investors' funds and allocated a significant amount for the formation of a deposit insurance fund.

🤝Our company has entered into an agreement with a leading international holding in the field of financial insurance with an annual turnover of over $ 70 billion. Half a century history, impeccable reputation and financial reliability of SOLLZO insurance partner are a guarantee of the safety of our investors' deposits.

🎉In the event of an insured event specified in the contract, the insurance company will reimburse SOLLZO investors for losses incurred as a result of this event.

The insurance fund is $ 150 million.

🛡Your money in the SOLLZO investment project is insured and protected by one of the largest and most reputable insurance companies in the world.

Investment security and consistently high profits on the SOLLZO platform guarantee you financial stability even in difficult conditions of the global economic crisis.

Get consistent, high returns on high-value assets at the intersection of two powerful and dynamic industries - healthcare and real estate.

💰By investing with SOLLZO, you are investing in your well-being!

,

05/08/2021

📌Sollzo announces rewards of up to 3% for the second quarter of 2021!

Dear Investors!

💎SOLLZO summed up the results for the second quarter of 2021 and showed strong growth in profit on main assets.

🎁On the occasion of financial success for this reporting period, the company announces the payment of a bonus to users of the investment platform.

For each new deposit in the online project Sollzo, a reward will be accrued in the form of a percentage to the amount of the deposit, and the net profit on the selected investment plan will increase by the same percentage.

💎You'll get:

+ 1.5% on plans:

Short

Normal

Proffesional

+ 2% on plans:

Silver

Gold

Platinum

+ 3% on plans:

Advanced

Advanced Pro

📆Offer valid until 14:00:00 GMT (GMT) on August 6, 2021.

📊Our second quarter results demonstrate the significant benefits of Sollzo's diversified portfolio. We have achieved strong results despite the unprecedented impact of the COVID-19 pandemic.

Medical real estate continues to offer compelling, demographically driven growth potential, and Sollzo is well positioned to capitalize on these powerful trends.

Occupancy rates for senior housing developments increased by 290 basis points from early April to late June, and profits for this asset class grew 62.5% compared to the first quarter of 2021.

The wide and effective introduction of vaccines since the beginning of 2021 has brought us tremendous benefits, with earnings on pharmaceutical stocks up 268% compared to the first quarter of 2021.

Financial stability and liquidity indicators:

As of July 5, 2021, the company has stable liquidity of $ 2.3 billion, including $ 2.3 billion in untapped renewable capacity, $ 0.3 billion in cash and cash equivalents, and $ 0.3 billion in outstanding commercial paper.

⬆️We are optimistic about our ongoing capital recycling initiatives to further improve the quality of our portfolio, fund new investment opportunities, and maintain financial strength and flexibility. The growing momentum in the healthcare industry, combined with our high quality portfolio and experienced leadership, enables Sollzo to achieve its goals and deliver outstanding results.

Get consistent, high returns on high-value assets at the intersection of two powerful and dynamic industries - healthcare and real estate.

💰By investing with SOLLZO, you are investing in your well-being!

,

02/08/2021

📌Reward 0.5% for reinvestment! Sollzo starts the formation process the Sollzo Living Real Estate targeted institutional Fund.

Dear Investors!

🎉On the occasion of the launch of the first stage of the creation of the Sollzo Living real estate fund, SOLLZO announces the payment of a bonus to the users of the investment platform.

🤝For each reinvestment from an account in the online project Sollzo, a reward of 0.5% will be credited to the amount of the deposit, and the net profit on the selected investment plan will also increase by 0.5%.

The offer is valid for all investment plans without restrictions.

💎Sollzo begins the process of forming a targeted institutional real estate fund Sollzo Living, which will focus on investments in healthcare and real estate for the elderly.

The fund will be launched during the fourth quarter of 2021 with assets in excess of $ 600 million under management.

The fund will provide funds for life sciences and medical offices and asset classes of residential real estate for the elderly, while generating dividends for Sollzo shareholders.

The targeted Fund will provide numerous strategic benefits for SOLLZO and its shareholders:

- formation of a new platform for constant growth of the company and an increase in significant investment potential;

- an increase in the company's profitability and an increase in the size of profit for SOLLZO investors;

- expanding the strategic coverage of SOLLZO;

- maximizing the influence of the SOLLZO brand;

- providing global institutional investors with the opportunity to invest in SOLLZO on a public or private investment structure.

📈By creating the Foundation, SOLLZO will contribute to a range of high quality sustainable life sciences and medicine office assets covering 1.1 million square feet. SOLLZO, as sponsor and general partner, will own 25% of the fund in order to participate in the stable cash flows that will be generated by the fund's portfolio. As a sponsor and general partner of the Fund, SOLLZO will receive a commission for asset management, and investors will receive an expected return.

Get consistent, high returns on high-value assets at the intersection of two powerful and dynamic industries - healthcare and real estate.

💰By investing with SOLLZO, you are investing in your well-being!

,

27/07/2021

📌Consensus forecast for high-cap stocks with strong growth. 92% of healthcare companies expect significant revenue growth in 2021.

Dear Investors!

📈Bullish market sentiment driven by the fast-paced vaccination drive and strong economic revival pushed benchmark indices to hit record highs in the first half of 2021. The healthcare industry has been one of the major beneficiaries of market optimism over the past few months. According to LBMC’s fourth annual Business Outlook Survey Report, 92% of healthcare organizations expect substantial revenue growth in 2021.

🎁The fundamentally sound large-cap companies Abbott Laboratories (ABT), Thermo Fisher Scientific (TMO), and Medtronic (MDT) are expected to grow significantly in the near term. Let’s look closer at these names.

⬆️ABT in Abbott Park, Ill., develops, manufactures, and sells health care products globally. Analysts expect ABT’s revenues to increase 13.5% year-over-year to $39.28 billion in the current year.

A $4.36 consensus EPS estimate for the current year represents a 19.5% rise versus last year. Shares of ABT have gained 21.9% over the past year and 7.3% year-to-date.

⬆️With a $205.01 billion market capitalization, Waltham, Mass.-based TMO is the world’s leader in the field of medical services.

A $35.66 billion consensus revenue estimate for the current year indicates a 10.7% increase year-over-year. The Street expects the company’s EPS to rise 13.1% from the prior year to $22.12 in the current year. TMO gained 32.5% over the past year. The stock has gained 11.6% year-to-date.

⬆️MDT develops, manufactures, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients across 150 countries.

The $33.2 billion consensus revenue estimate for the current year represents a 10.3% improvement from the last year. Analysts expect the company’s EPS to come in at $5.68 in the current year, indicating a 27.9% rise year-over-year. Moreover, MDT surpassed the Street’s EPS estimates in each of the trailing four quarters.

💎Given the rising demand for healthcare services worldwide and robust tech integration in the industry, we think betting on large-cap stocks, which possess solid growth attributes, could be rewarding.

Get consistent, high returns on high-value assets at the intersection of two powerful and dynamic industries - healthcare and real estate.

💰By investing with SOLLZO, you are investing in your well-being!

,

24/07/2021

📌Stock market overview in the healthcare sector. In the second quarter, the healthcare sector showed a significant increase in profits of 16.7%.

Dear Investors!

🤝SOLLZO owns over $ 890 million in shares and stakes in major pharmaceutical companies such as Johnson & Johnson, Pfizer, AbbVie, Roche and others. These assets generate huge cash flow, providing SOLLZO investors with consistently high returns.

Let's dive into the big picture of these companies that will determine their profitability in the coming days.

⬆️Earnings expectations of the healthcare sector are upbeat as the sector is likely to log 14.6% growth in the second quarter of 2021 on revenue growth of 15.7%, per the Earnings Trends issued on Jul 14, 2021.

🦠The spread of the Delta variant of COVID-19 should boost demand for vaccine makers, and other pharma and healthcare companies.

🧬The healthcare sector has been benefiting from COVID-19 vaccines or treatment with many more to come. The ultra-popular ETFs - Health Care Select Sector SPDR Fund XLV, Vanguard Health Care ETF VHT, iShares U.S. Healthcare ETF IYH and Fidelity MSCI Health Care Index ETF FHLC, have gained around 5% over the past three months.

⬆️Most recently, Moderna, known for its success in the COVID-19 vaccine, entered the big league with its addition to the S&P 500 Index. The S&P announced this late Thursday night, and the next day, July 16, Moderna shares rose 10.3%, on 4.5 times volume. The stock was up nearly 175% this year last week, leading to Moderna’s market valuation of more than $115 billion.

📊Better-than-expected earnings results from Johnson & Johnson JNJ and UnitedHealth Group UNH have added to the strength. The world's biggest healthcare products’ maker continued its long streak of earnings beat and outpaced revenue estimates.

⬆️Pfizer has a Zacks Rank #3 and an Earnings ESP of +2.51%. It delivered an earnings surprise of 8.44%, on average, in the past four quarters and has a VGM Score of B.

⬆️Thermo Fisher carries a Zacks Rank #3 and has an Earnings ESP of +2.69%. The earnings surprise track over the past four quarters is strong, with the beat being 21.41%, on average.

💰 Get consistent, high returns on high-value assets at the intersection of two powerful and dynamic industries - healthcare and real estate.
By investing with SOLLZO, you are investing in your well-being!

,

09/03/2021

🌐 To attract funds from individuals in order to increase working capital, we launched an online investment project with high interest rates on deposits.
➡️ http://sollzo.com
🔹 Through the online investment platform Sollzo, private investors from different countries now have the opportunity to invest in the most highly profitable and stable sectors of the health care sector - pharmaceuticals and medical real estate, and receive stable high profits from expensive assets.

09/03/2021

📈 Acquisition of shares of the biggest pharmaceutical companies

🔸 Sollzo acquires shares and stakes in major pharmaceutical companies such as Johnson & Johnson, Pfizer, AbbVie, Roche and others, which generate huge cash flow, providing investors with consistently high returns.

🔸 The global pharmaceutical market volume of more than 1.4 trillion USD is the most profitable industry in the global economy.

08/03/2021

🏗️ Investing in the construction of health facilities

🔹 Sollzo invests in the construction of healthcare real estate. Investors and customers of medical real estate are government organizations in the UK, USA and Canada, commercial companies and NGOs.

🔹 About 2% of real estate remains in the ownership of the company for the provision of leasing and property management services.

08/03/2021

🏥 Leasing and property management services

🔸 Sollzo has provided leasing and property management services at 24.3 MMSF.

🔸 We invest in leading healthcare networks for the care and provision of medical care, including general hospitals, medical centers, outpatient facilities and pension communities.

🔸 Our company focuses on partnerships with state and commercial health care providers who are financially sound and provide high quality medical care.

08/03/2021

💎 Investing in a high-quality living environment for elderly people

🔹 Sollzo owns residential complexes for the elderly located in the UK, USA and Canada with a total area of 12.2 MMSF.

🔹 The company invests in industry-leading operators with industry-wide scope and industry-specific skills in caring for the elderly.

08/03/2021

🏢 Company strong and stable with many years of experience in successful development and asset management in dynamic and complex market conditions.

Sollzo

12/08/2021

09/08/2021

05/08/2021

02/08/2021

27/07/2021

24/07/2021

09/03/2021

09/03/2021

08/03/2021

08/03/2021

08/03/2021

08/03/2021

Address

Website

Alerts

Shortcuts

Share

Category